Insulet Reports Third Quarter 2020 Revenue Increase of 22% Year-Over-Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq rise in choppy trading as tech steadies, Micron results in focus
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Insulet (PODD) Tops Q3 EPS by 9c, Revenues Beat; Raises Revenue Guidance Growth Range
November 4, 2020 5:34 PM ESTInsulet (NASDAQ: PODD) reported Q3 EPS of $0.17, $0.09 better than the analyst estimate of $0.08. Revenue for the quarter came in at $234 million versus the consensus estimate of $221.68 million.
Third Quarter Financial Highlights:
Third quarter 2020 revenue of $234.0 million, up 21.8%, or 19.9% in constant currency1, compared to $192.1 million in the prior year, exceeds guidance of 13% to 15% on a constant currency basisTotal Omnipod revenue of $212.1 million, an increase of 19.7%, or 17.6% in constant currencyU.S. Omnipod revenue of $132.3 million, an increase of 20.9%International Omnipod revenue of $79.8 million, an increase of 17.7%, or 12.4% in constant... More